Use of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root ganglia in sjögren patients with neuropathic pain: Case series of 10 patients and review of the literature

Medicine (United States)

Volumn 93, Issue 3, 2014, Pages 121-134

  Birnbaum, Julius ^a   Duncan, Trisha ^a   Owoyemi, Kristie ^a   Wang, Kenneth C ^b   Carrino, John ^b   Chhabra, Avneesh ^b  

^a Division of Rheumatology   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GADOLINIUM PENTETATE; IMMUNOGLOBULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; DEMYELINATING NEUROPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG RESPONSE; ELECTRON SPIN RESONANCE; FEMALE; FOLLOW UP; HIGH RESOLUTION MAGNETIC RESONANCE NEUROGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; INTRAEPIDERMAL NERVE FIBER DENSITY; MALE; MONONEUROPATHY; MONONEUROPATHY MULTIPLEX; NERVE FIBER; NEUROGRAPHY; NEUROPATHIC PAIN; NONMYELINATED NERVE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; POLYRADICULONEUROPATHY; PREVALENCE; PRIORITY JOURNAL; RADICULOPATHY; RADIODIAGNOSIS; SENSORIMOTOR NEUROPATHY; SJOEGREN SYNDROME; SKIN BIOPSY; SMALL FIBER NEUROPATHY; SPINAL GANGLION; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; BIOPSY; COHORT STUDIES; FEMALE; GANGLIA, SPINAL; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS; NEURALGIA; PERIPHERAL NERVOUS SYSTEM DISEASES; SJOGREN'S SYNDROME; UNITED STATES; YOUNG ADULT;

EID: 84900442821     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000024     Document Type: Article

References (79)

1. Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM. The spectrum of neurological involvement in Sjogren's syndrome. Br J Rheumatol. 1990;29:21-23.
2. Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM. Neurologic involvement in primary Sjogren's syndrome: a preliminary report. J Autoimmun. 1989;2:485-488.
3. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, Lombardi R, Hermans MC, van Nes SI, De Baets M, Faber CG. Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology. 2009;73:1142-1148.
4. Baron R. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol. 2006;2:95-106.
5. Bennett DL, Vincent A. Autoimmune pain: an emerging concept. Neurology. 2012;79:1080-1081.
6. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005;6:149-158.
7. Birnbaum J. Peripheral neuropathy is an uncommon cause of neuropathic symptoms in Sjogrens patients [abstract]. Arthritis Rheum. 2009;60(Suppl 10):506.
8. Birnbaum J. Peripheral nervous system manifestations of Sjogren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist. 2010;16:287-297.
9. Bliddal H, Boesen M, Christensen R, Kubassova O, Torp-Pedersen S. Imaging as a follow-up tool in clinical trials and clinical practice. Best Pract Res Clin Rheumatol. 2008;22:1109-1126.
10. Brannagan THIII, Hays AP, Chin SS, Sander HW, Chin RL, Magda P, Green PH, Latov N. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch Neurol. 2005;62:1574-1578.
11. Brito-Zeron P, Akasbi M, Bosch X, Bove A, Perez-De-Lis M, Diaz-Lagares C, Retamozo S, Gandia M, Perez-Alvarez R, Soto-Cardenas MJ, Siso A, Valls-Sole J, Graus F, Ramos-Casals M. Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjogren's syndrome. Clin Exp Rheumatol. 2013;31:103-110.
12. Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjogren syndrome. Neurology. 2005;65:925-927.
13. Chai J, Logigian EL. Neurological manifestations of primary Sjogren's syndrome. Curr Opin Neurol. 2010;13:509-513.
14. Dabby R, Sadeh M, Gilad R, Lampl Y, Cohen S, Inbar S, Leshinsky-Silver E. Chronic non-paroxysmal neuropathic pain-Novel phenotype of mutation in the sodium channel SCN9A gene. J Neurol Sci. 2011;301:90-92.
15. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83:280-291.
16. Drosos AA, Andonopoulos AP, Lagos G, Angelopoulos NV, Moutsopoulos HM. Neuropsychiatric abnormalities in primary Sjogren's syndrome. Clin Exp Rheumatol. 1989;7:207-209.
17. Fauchais AL, Magy L, Vidal E. Central and peripheral neurological complications of primary Sjogren's syndrome. Presse Med. 2012;41:e485-e493.
18. Fauchais AL, Martel C, Gondran G, Lambert M, Launay D, Jauberteau MO, Hachulla E, Vidal E, Hatron PY. Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease. Autoimmun Rev. 2010;9:595-599.
19. Fauchais AL, Richard L, Gondran G, Ghorab K, Palat S, Bezanahary H, Loustaud-Ratti V, Ly K, Jauberteau MO, Vallat JM, Vidal E, Magy L. Small fibre neuropathy in primary Sjogren syndrome. Rev Med Interne. 2011;32:142-148.
20. Flatters SJ, Bennett GJ. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain. 2006;122:245-257.
21. Fox PC, Bowman SJ, Segal B, Vivino FB, Murukutla N, Choueiri K, Ogale S, McLean L. Oral involvement in primary Sjogren syndrome. J Am Dent Assoc. 2008;139:1592-1601.
22. Fox RI. Sjogren's syndrome. Lancet. 2005;366:321-331.
23. Fox RI, Michelson P. Approaches to the treatment of Sjogren's syndrome. J Rheumatol Suppl. 2000;61:15-21.
24. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjogren's syndrome. Proposed criteria for classification. Arthritis Rheum. 1986;29:577-585.
25. Garcia-Carrasco M, Ramos-Casals M, Rosas J, Pallares L, Calvo-Alen J, Cervera R, Font J, Ingelmo M. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270-280.
26. Gemignani F, Ferrari G, Vitetta F, Giovanelli M, Macaluso C, Marbini A. Non-length-dependent small fibre neuropathy. Confocal microscopy study of the corneal innervation. J Neurol Neurosurg Psychiatry. 2010;81:731-733.
27. Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, Mancia D. Peripheral neuropathy associated with primary Sjogren's syndrome. J Neurol Neurosurg Psychiatry. 1994;57:983-986.
28. Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H. Clinical manifestations of neurological involvement in primary Sjogren's syndrome. Clin Rheumatol. 2011;30:485-490.
29. Goransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellgren SI, Omdal R. Peripheral neuropathy in primary sjogren syndrome: a population-based study. Arch Neurol. 2006;63:1612-1615.
30. Gorson KC, Herrmann DN, Thiagarajan R, Brannagan TH, Chin RL, Kinsella LJ, Ropper AH. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry. 2008;79:163-169.
31. Govoni M, Bajocchi G, Rizzo N, Tola MR, Caniatti L, Tugnoli V, Colamussi P, Trotta F. Neurological involvement in primary Sjogren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol. 1999;18:299-303.
32. Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48:855-862.
33. Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann Neurol. 1990;27:304-315.
34. Harboe E, Tjensvoll AB, Maroni S, Goransson LG, Greve OJ, Beyer MK, Herigstad A, Kvaloy JT, Omdal R. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study. Ann Rheum Dis. 2009;68:1541-1546.
35. Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H. Nervous system manifestations in Sjogren's syndrome. Acta Neurol Scand. 1990;81:144-152.
36. Hoeijmakers JG, Merkies IS, Gerrits MM, Waxman SG, Faber CG. Genetic aspects of sodium channelopathy in small fiber neuropathy. Clin Genet. 2012;82:351-358.
37. Karabiyik A, Peck AB, Nguyen CQ. The important role of T cells and receptor expression in Sjogren's syndrome. Scand J Immunol. 2013;78:157-166.
38. Kawagashira Y, Koike H, Fujioka Y, Hashimoto R, Tomita M, Morozumi S, Iijima M, Katsuno M, Tanaka F, Sobue G. Differential, size-dependent sensory neuron involvement in the painful and ataxic forms of primary Sjogren's syndrome-associated neuropathy. J Neurol Sci. 2012;15:139-146.
39. Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G. Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogren's syndrome. J Neurol Neurosurg Psychiatry. 2006;77:967-969.
40. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology. 2012;79:1136-1144.
41. Lacomis D. Small-fiber neuropathy. Muscle Nerve. 2002;26:173-188.
42. Lafitte C, Amoura Z, Cacoub P, Pradat-Diehl P, Picq C, Salachas F, Leger JM, Piette JC, Delattre JY. Neurological complications of primary Sjogren's syndrome. J Neurol. 2001;248:577-584.
43. Lauria G, Devigili G. Skin biopsy as a diagnostic tool in peripheral neuropathy. Nat Clin Pract Neurol. 2007;3:546-557.
44. Lopate G, Pestronk A, Al-Lozi M, Lynch T, Florence J, Miller T, Levine T, Rampy T, Beson B, Ramneantu I. Peripheral neuropathy in an outpatient cohort of patients with Sjogren's syndrome. Muscle Nerve. 2006;33:672-676.
45. Martinez-Lavin M, Vaughan JH, Tan EM. Autoantibodies and the spectrum of Sjogren's syndrome. Ann Intern Med. 1979;91:185-190.
46. Mauch E, Volk C, Kratzsch G, Krapf H, Kornhuber HH, Laufen H, Hummel KJ. Neurological and neuropsychiatric dysfunction in primary Sjogren's syndrome. Acta Neurol Scand. 1994;89:31-35.
47. McArthur JC. Painful small fiber neuropathies. Continuum (Minneap Minn). 2012;18:106-125.
48. McArthur JC, Griffin JW. Another tool for the neurologist's toolbox. Ann Neurol. 2005;57:163-167.
49. McArthur JC, Stocks EA, Hauer P, Cornblath DR, Griffin JW. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol. 1998;55:1513-1520.
50. McKelvey L, Shorten GD, O'Keeffe GW. Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management. J Neurochem. 2013;124:276-289.
51. Mellgren SI, Goransson LG, Omdal R. Primary Sjogren's syndrome associated neuropathy. Can J Neurol Sci. 2007;34:280-287.
52. Molina JA, Benito-Leon J, Bermejo F, Jimenez-Jimenez FJ, Olivan J. Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjogren's syndrome. J Neurol Neurosurg Psychiatry. 1996;60:699.
53. Molina R, Provost TT, Arnett FC, Bias WB, Hochberg MC, Wilson RW, Alexander EL. Primary Sjogren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med. 1986;80:23-31.
54. Moll JW, Markusse HM, Pijnenburg JJ, Vecht CJ, Henzen-Logmans SC. Antineuronal antibodies in patients with neurologic complications of primary Sjogren's syndrome. Neurology. 1993;43:2574-2581.
55. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005;128(11):2518-2534.
56. Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, Tanaka F, Sobue G. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci. 2009;279:57-61.
57. Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain. 2001;92:139-145.
58. Pavlakis PP, Alexopoulos H, Kosmidis ML, Mamali I, Moutsopoulos HM, Tzioufas AG, Dalakas MC. Peripheral neuropathies in Sjogren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun. 2012;39:27-33.
59. Pavlakis PP, Alexopoulos H, Kosmidis ML, Stamboulis E, Routsias JG, Tzartos SJ, Tzioufas AG, Moutsopoulos HM, Dalakas MC. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry. 2011;82:798-802.
60. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci. 2006;29:507-538.
61. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, Calvo-Alen J, Jimenez-Alonso J, Mico ML, Beltran J, Belenguer R, Pallares L, GEMESS Study Group. Primary Sjogren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine (Baltimore). 2008;87:210-219.
62. Rist S, Sellam J, Hachulla E, Sordet C, Puechal X, Hatron PY, Benhamou CL, Sibilia J, Mariette X, Club Rhumatismes et Inflammation. Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjogren's syndrome: a national multicentric retrospective study. Arthritis Care Res (Hoboken). 2011;63:1339-1344.
63. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361-1368.
64. Segal B, Carpenter A, Walk D. Involvement of nervous system pathways in primary Sjogren's syndrome. Rheum Dis Clin North Am. 2008;34:885-906, viii.
65. Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM. Pain severity and neuropathic pain symptoms in primary Sjogren's syndrome: a comparison study of seropositive and seronegative Sjogren's syndrome. Arthritis Care Res (Hoboken). 2013;65:1291-1298.
66. Seidel MF, Herguijuela M, Forkert R, Otten U. Nerve growth factor in rheumatic diseases. Semin Arthritis Rheum. 2010;4:109-126.
67. Sene D, Jallouli M, Lefaucheur JP, Saadoun D, Costedoat-Chalumeau N, Maisonobe T, Diemert MC, Musset L, Haroche J, Piette JC, Amoura Z, Cacoub P. Peripheral neuropathies associated with primary Sjogren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine (Baltimore). 2011;90:133-138.
68. Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum. 2000;29:296-304.
69. Skopouli FN, Fox PC, Galanopoulou V, Atkinson JC, Jaffe ES, Moutsopoulos HM. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjogren's syndrome. J Rheumatol. 1991;18:210-214.
70. Skopouli FN, Moutsopoulos HM. Autoimmune epitheliitis: Sjogren's syndrome. Clin Exp Rheumatol. 1994;12:S9-S11.
71. Soldatos T, Andreisek G, Thawait GK, Guggenberger R, Williams EH, Carrino JA, Chhabra A. High-resolution 3-T MR neurography of the lumbosacral plexus. Radiographics. 2013;33:967-987.
72. Sutcliffe N, Inanc M, Speight P, Isenberg D. Predictors of lymphoma development in primary Sjogren's syndrome. Semin Arthritis Rheum. 1998;28:80-87.
73. Terrier B, Lacroix C, Guillevin L, Hatron PY, Dhote R, Maillot F, Diot E, Sarrot-Reynauld F, Sordet C, Dubourg O, Meyer L, Mariette X, Gottenberg JE. Club Rhumatismes et Inflammation. Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjogren's syndrome-related neuropathy. Arthritis Rheum. 2007;57:1520-1529.
74. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
75. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340-347.
76. Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjogren's syndrome. Nat Rev Rheumatol. 2010;6:529-537.
77. Wakasugi D, Kato T, Gono T, Ito E, Nodera H, Kawaguchi Y, Yamanaka H, Hara M. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod Rheumatol. 2009;19:437-440.
78. Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain. 1991;44:105-117.
79. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol. 2001;429:23-37.